InvestorsHub Logo

jmh0602

01/18/17 8:27 PM

#2664 RE: Chess Master #2663

I bought in three years ago so I don't remember, but the small amount of research I did leads me to believe DAVANAT is the old name for GR-MD-01, looks like it was close to FDA approval, but I couldn't find the punch line. It just seems everything stopped for some reason. What happened?

gss2003

01/18/17 10:13 PM

#2665 RE: Chess Master #2663

Agree, MRK should buy it, accelerate the trials and work towards oral version and go after additional indications. Atopic alone is worth $1b or more

ARIA had peak sales estimate of $1b and sold for 5x